Genentech granted FDA orphan status for gastric cancer treatment

theflyonthewall.com

Roche's Genentech unit was granted FDA orphan designation for Ipatasertib for the treatment of gastric cancer including cancer of the gastro-esophageal junction, according to a post to the FDA website.

View Comments (0)